SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A-1
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarter Ended June 30, 1995 Commission File No. 0-15443
THERAGENICS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 58-1528626
(State of incorporation) (I.R.S. Employer Identification Number)
5325 Oakbrook Parkway
Norcross, Georgia 30093
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (404)381-8338
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days. YES X NO
Indicate the number of shares outstanding of each of the issuers
classes of common stock, as of the latest practicable date:
CLASS Shares Outstanding at August 3, 1995
Common Stock, 11,071,985
par value $.01
<PAGE>
<PAGE>
Item 6.- Exhibits and Reports on Form 8-K
(a) Exhibits
Exhibit 27 - Financial Data Schedule
(b) Reports on Form 8-K.
The company filed a Report on Form 8-K dated June
29, 1995, reporting the signing of two agreements,
each for the purchase of one cyclotron from the
manufacturer of the Company's current two
cyclotrons.
<PAGE>
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
REGISTRANT:
THERAGENICS CORPORATION
By: /s/ M. Christine Jacobs
M. Christine Jacobs
President
PRINCIPAL FINANCIAL OFFICER:
/s/ Bruce W. Smith
Bruce W. Smith
Treasurer and
Chief Financial Officer
Dated: September 26, 1995
<PAGE>
<PAGE>
THERAGENIC CORPORATION
INDEX TO EXHIBITS
Page No.
27 Financial Data Schedule 5
<PAGE>
<PAGE>
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted
from SEC Form 10-Q and is qualified in its entirety by reference
to such financial statements.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1995
<PERIOD-END> JUN-30-1995
<CASH> 3,139,502
<SECURITIES> 0
<RECEIVABLES> 1,078,623
<ALLOWANCES> 0
<INVENTORY> 216,526
<CURRENT-ASSETS> 4,532,729
<PP&E> 10,257,036
<DEPRECIATION> 1,746,014
<TOTAL-ASSETS> 14,884,147
<CURRENT-LIABILITIES> 982,071
<BONDS> 1,269,778
<COMMON> 15,372,818
0
0
<OTHER-SE> (2,740,520)
<TOTAL-LIABILITY-AND-EQUITY> 14,884,147
<SALES> 3,660,678
<TOTAL-REVENUES> 3,810,358
<CGS> 1,274,928
<TOTAL-COSTS> 2,566,723
<OTHER-EXPENSES> (7,340)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 1,236,295
<INCOME-TAX> 469,792
<INCOME-CONTINUING> 766,503
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 766,503
<EPS-PRIMARY> .07
<EPS-DILUTED> .07
</TABLE>
